Feely J, Chan R, Cocoman L, Mulpeter K, O'Connor P
Department of Pharmacology and Therapeutics, Trinity College Medical School, St James's Hospital, Dublin, Ireland.
BMJ. 1990 Jan 6;300(6716):28-30. doi: 10.1136/bmj.300.6716.28.
The effects of introducing a hospital formulary alone and with active intervention were compared prospectively with regard to drug costs and the quality of prescribing. Intervention comprised feedback on prescribing habits, peer comparison, and information on drugs. Aspects of prescribing that were not subjected to intervention did not alter. In the year in which intervention occurred generic prescribing rose by 50%; inappropriate prescribing and overall use of third generation cephalosporins fell; and compliance with the recommended list of drugs was good. Overall, drug costs remained static, compared with a projected increase of 0.25 m pounds; in a comparative control hospital drug costs rose by 18%. During the next year, when no form of intervention took place, previous gains were eroded and drug costs rose. Continuous intervention, review, and feedback are required if a formulary is to continue to achieve its objectives.
前瞻性地比较了单独引入医院药品处方集以及引入并进行积极干预这两种情况对药品成本和处方质量的影响。干预措施包括对处方习惯的反馈、同行比较以及药品信息。未受干预的处方方面没有变化。在进行干预的那一年,通用名药物的处方量增长了50%;不适当处方和第三代头孢菌素的总体使用量下降;对推荐药品清单的依从性良好。总体而言,药品成本保持不变,而预计会增加25万英镑;在一家对照医院,药品成本上升了18%。在接下来的一年,当没有进行任何形式的干预时,之前取得的成果被侵蚀,药品成本上升。如果要使药品处方集继续实现其目标,就需要持续的干预、审查和反馈。